FDA to consider ‘innovative approaches’ to psychedelic drug development
Top US Food and Drug Administration (FDA) officials said the agency is open to novel, “innovative approaches” to the clinical development of psychedelic drugs in light of the worsening mental health crisis in the US.
comments(0)
5-min edit window · permanent after that